Delivery Order SPE2DB25D7056-SPE2DB25FTMXQ
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of NESACAINE-MPF 3% VIAL 20ML, a pharmaceutical product, to support military treatment programs and facilities. The contract has a ceiling value of $1,923.31 and a period of performance through March 20, 2024. It is a firm fixed price contract, with no...
- The Defense Logistics Agency awarded a $5,475 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Nesacaine-MPF 3% vials (20 mL) under a firm fixed-price contract structure. The award is non-competitive with no set-aside designation and is scheduled for completion by January 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of parent company Cencora, Inc., which is a major pharmaceutical distributor...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Nesacaine-MPF 3% anesthetic solution in 20 mL vials. The contract has a firm fixed price of $1,215.99 and a completion date of October 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical anesthetic products to support military treatment facilities and other federal healthcare providers. The contract is not associated with a...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $1,542.24 to AmerisourceBergen Drug Corp on August 20, 2025, with an ultimate completion date of August 21, 2025. This contract is classified as a child award under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order utilizes firm fixed-price pricing and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xylocaine-MPF 1% Vial 5ML, a local anesthetic medication commonly used in medical and surgical applications. This firm fixed-price delivery order, valued at $2,413.46, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- This delivery order, valued at $1,069.20, was awarded to AmerisourceBergen Drug Corp on October 4, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of October 6, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery contract vehicle, this delivery order represents one of numerous...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $55,543.32 to AmerisourceBergen Drug Corp on August 4, 2025, under a firm fixed-price contract with an ultimate completion date of August 5, 2025. This non-set-aside award was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for pharmaceutical supplies valued at $1,184.60, with completion scheduled for January 22, 2026. The award covers a 0.25% drop formulation in 10ml units and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $275,118.44 to AmerisourceBergen Drug Corp on August 23, 2025, for pharmaceutical and medical supply delivery. This firm fixed price delivery order, which concludes August 25, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $1,749.70 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This contract, effective December 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...